|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.95 USD | -1.95% |
|
+2.95% | -28.00% |
| 16/07 | RxSight Names Aziz Mottiwala as CEO | MT |
| 14/07 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Market Cap | 253.63Cr 222.58Cr 207.27Cr 190.64Cr 357.37Cr 24TCr 363.5Cr 2.46TCr 962.49Cr 12TCr 952.16Cr 931.59Cr 42TCr | P/E 2026 * |
-28.2x | P/E 2027 * | 35.5x |
|---|---|---|---|---|---|
| Enterprise Value | 253.63Cr 222.58Cr 207.27Cr 190.64Cr 357.37Cr 24TCr 363.5Cr 2.46TCr 962.49Cr 12TCr 952.16Cr 931.59Cr 42TCr | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 2.82x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | -1.95% | ||
| 1 week | +2.95% | ||
| Current month | -6.34% | ||
| 1 month | -6.31% | ||
| 3 months | -5.06% | ||
| 6 months | -8.15% | ||
| Current year | -28.00% |
| 1 week | 56.38 |  | 61.36 |
| 1 month | 53.89 | | 72.5 |
| Current year | 53.89 | | 83.92 |
| 1 year | 38.51 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Director | 6,254 | 0.0145% | ||
| 25/06/26 | Free | Director | 6,254 | 0.0145% | ||
| 25/06/26 | Free | Director | 7,463 | 0.0173% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.95% | +2.95% | +41.20% | +157.31% | 253.63Cr | |
| +4.20% | +2.96% | +24.44% | -6.82% | 7.07TCr | |
| +0.12% | +2.96% | +35.37% | +211.10% | 5.43TCr | |
| +0.26% | +54.90% | +54.90% | +54.90% | 4.93TCr | |
| +7.15% | +8.59% | -52.92% | -52.31% | 3.99TCr | |
| +2.73% | +1.21% | +59.04% | -22.48% | 3.04TCr | |
| +9.30% | +10.68% | +85.19% | +105.94% | 2.6TCr | |
| +0.31% | -6.46% | +64.57% | -52.97% | 2.21TCr | |
| -0.22% | -2.76% | -10.26% | +159.25% | 2TCr | |
| +1.70% | +3.76% | +85.05% | +148.55% | 1.68TCr | |
| Average | +2.35% | +2.66% | +38.66% | +70.25% | 3.32TCr | |
| Weighted average by Cap. | +2.86% | +3.36% | +33.14% | +55.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 71Cr 63Cr 58Cr 54Cr 100.41Cr 6.81TCr 102.14Cr 690.94Cr 270.44Cr 3.38TCr 267.54Cr 261.76Cr 12TCr | 90Cr 79Cr 74Cr 68Cr 126.86Cr 8.6TCr 129.03Cr 872.87Cr 341.65Cr 4.27TCr 337.99Cr 330.69Cr 15TCr |
| Net income | -9.27Cr -8.14Cr -7.58Cr -6.97Cr -13Cr -885.7Cr -13Cr -90Cr -35Cr -439.25Cr -35Cr -34Cr -1.52TCr | 8.27Cr 7.26Cr 6.76Cr 6.22Cr 12Cr 790.29Cr 12Cr 80Cr 31Cr 391.93Cr 31Cr 30Cr 1.35TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $58.95 | -1.95% | 5,10,219 |
| 27/26/27 | $60.12 | +2.49% | 7,25,405 |
| 24/26/24 | $58.66 | +0.14% | 4,46,509 |
| 23/26/23 | $58.58 | +1.74% | 10,88,820 |
| 22/26/22 | $57.58 | +0.56% | 12,83,049 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions
